Assurance de qualité pour le cancer rectal – phase 2 ...

More documents

Recommendations

Info

146 PROCARE – phase 2 KCE reports 81DISTAL TUMOUR-FREE MARGIN MENTIONED IN THEPATHOLOGY REPORTMeasurement in prospective PROCARE database (Figure 56)In the hospital data section of the PROCARE data entry form, the variable ‘AD_V111’ ischecked if the patient underwent rectal surgery. Patients undergoing radical resectivesphincter saving surgery with curative intent are selected using variable ‘SG_V234’(subcodes 5-9).The distal tumour-free margin is registered through variable ‘PT_V140’ in the pathologysection.Measurement in coupled administrative databaseNo administrative code exists for the distal tumour-free margin, which are also datathat can only be retrieved from the medical file.Figure 56. Algorithm for QI 1273 (prospective database).All patientsN=1071SurgeryN=1058SSO or HartmannsurgeryN=815Pathology reportN=777Surgery?SSO orHartmannsurgery?Pathologyreport?Distal tumour-freemarginmentioned?Distal tumour-freemargin mentionedN=69589,45%NO SSO orHartmann surgeryN=192No surgeryN=13Distal tumour-freemargin: MISSINGSSO or Hartmannsurgery?=MISSING N=82N=51No pathology reportN=38
KCE Reports 81 PROCARE – phase 2 147NUMBER OF LYMPH NODES EXAMINEDMeasurement in prospective PROCARE database (Figure 57 and Figure 58)In the hospital data section of the PROCARE data entry form, the variable ‘AD_V111’ ischecked if the patient underwent rectal surgery. Patients undergoing radical resectionare selected using variables ‘SG_V168’, ‘SG_V210’, ‘SG_V216’ and ‘SG_V234’.Number of lymph nodes examined is registered through variable ‘PT_V142’ in thepathology section.Since neoadjuvant radiotherapy has an important influence on the number of retrievedlymph nodes, results are presented taking into account the receival of a long course ofneoadjuvant radiotherapy vs. no neoadjuvant radiotherapy or a short course ofneoadjuvant radiotherapy vs. another course of neoadjuvant radiotherapy (using thesame calculations as for QI 1221 and 1222).Measurement in coupled administrative databaseNo administrative code exists for the number of lymph nodes examined, which are alsodata that can only be retrieved from the medical file.Figure 57. Algorithm for QI 1274, part 1 (prospective database).All patientsN=1071Surgery?Radical surgeryN=1018NeoadjuvanttherapyN=584Type ofRT?Long course(Total dose >=45)N=415Short course(Total dose 1-25)N=66N° of lymph nodesexamined knownN=401N° of lymph nodesexamined not knownN=14N° of lymph nodesexamined knownN=63 N=4N° of lymph nodesexamined not knownN=3Neoadjuvanttreatment?Other course(Total dose 26-44)N=26N° of lymph nodesexamined knownN=25N° of lymph nodesexamined not knownN=1No radicalsurgeryN=40No NeoadjuvanttherapyCourse: MissingN=76N° of lymph nodesexamined knownN=73N° of lymph nodesexamined not knownN=3No surgeryN=13N=312Neoadjuvanttherapy:MISSINGN=122No neoadjuvantradiotherapyN=1N° of lymph nodesexamined knownN=1N° of lymph nodesexamined not knownN=0
Page 1 and 2:
Assurance de qualitépour le cancer
Page 3 and 4:
Assurance de qualité pour lecancer
Page 5 and 6:
KCE Reports 81B Cancer rectal - pha
Page 7:
KCE Reports 81B Cancer rectal - pha
Page 10 and 11:
vi Cancer rectal - phase 2 KCE Repo
Page 12 and 13:
2 PROCARE - phase 2 KCE reports 81A
Page 14 and 15:
4 PROCARE - phase 2 KCE reports 811
Page 16 and 17:
6 PROCARE - phase 2 KCE reports 81F
Page 19 and 20:
KCE Reports 81 PROCARE - phase 2 92
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
KCE Reports 81 PROCARE - Phase 2 77
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106: KCE Reports 81 PROCARE - phase 2 95
Page 155: KCE Reports 81 PROCARE - phase 2 14
Page 169: KCE Reports 81 PROCARE - phase 2 15
Page 172 and 173: Dépôt légal : D/2008/10.273/39
Page 174 and 175: 35. Etude relative aux coûts poten
show all

Assurance de qualité pour le cancer rectal – phase 2 ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?